{"id":{"repo_id":"bradford","oai_identifier":"oai:bradscholars.brad.ac.uk:10454/20834"},"canonical_url":"https://search.dev.ndltd.org/etd/bradford/oai:bradscholars.brad.ac.uk:10454/20834","repository":{"repo_id":"bradford","name":"University of Bradford","base_url":"https://bradscholars.brad.ac.uk/oai/request"},"display":{"title":"Drug repurposing and engineering nanotechnology-based delivery systems: A strategy to overcome chemoresistance in Malignant Pleural Mesothelioma","abstract":"","abstract_html":null,"abstract_has_math":false,"creators":["Walker, Harriet R."],"institution":"University of Bradford","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Ruiz, Amalia","Crawford, Deborah E.","Moody, Hannah L."],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-07-24T01:15:08Z","subjects":["Malignant Pleural Mesothelioma (MPM)","Exportin-1","KPT-330","Auranofin","CD-44 receptor","Hydrogel","Nanotechnology","Drug delivery system","Reactive oxygen species (ROS)"],"languages":["en"],"rights":["<a rel=\"license\" href=\"http://creativecommons.org/licenses/by-nc-nd/3.0/\"><img alt=\"Creative Commons License\" style=\"border-width:0\" src=\"http://i.creativecommons.org/l/by-nc-nd/3.0/88x31.png\" /></a><br />The University of Bradford theses are licenced under a <a rel=\"license\" href=\"http://creativecommons.org/licenses/by-nc-nd/3.0/\">Creative Commons Licence</a>."],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://bradscholars.brad.ac.uk/handle/10454/20834","outbound_label":"Repository record","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Ruiz, Amalia","Crawford, Deborah E.","Moody, Hannah L."]},{"key":"dc:creator","label":"Author","values":["Walker, Harriet R."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-03-11T15:19:44Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2026-03-11T15:19:44Z"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["School of Pharmacy and Medical Sciences. Faculty of Life Sciences"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Bradford"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["doctoral"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Malignant Pleural Mesothelioma (MPM)","Exportin-1","KPT-330","Auranofin","CD-44 receptor","Hydrogel","Nanotechnology","Drug delivery system","Reactive oxygen species (ROS)"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["<a rel=\"license\" href=\"http://creativecommons.org/licenses/by-nc-nd/3.0/\"><img alt=\"Creative Commons License\" style=\"border-width:0\" src=\"http://i.creativecommons.org/l/by-nc-nd/3.0/88x31.png\" /></a><br />The University of Bradford theses are licenced under a <a rel=\"license\" href=\"http://creativecommons.org/licenses/by-nc-nd/3.0/\">Creative Commons Licence</a>."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://bradscholars.brad.ac.uk/handle/10454/20834"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:title","label":"Title","values":["Drug repurposing and engineering nanotechnology-based delivery systems: A strategy to overcome chemoresistance in Malignant Pleural Mesothelioma"]}]}],"canonical_facts":{"dc:contributor.advisor":["Ruiz, Amalia","Crawford, Deborah E.","Moody, Hannah L."],"dc:creator":["Walker, Harriet R."],"dc:date.accessioned":["2026-03-11T15:19:44Z"],"dc:date.available":["2026-03-11T15:19:44Z"],"dc:identifier.uri":["https://bradscholars.brad.ac.uk/handle/10454/20834"],"dc:language.iso":["en"],"dc:publisher.department":["School of Pharmacy and Medical Sciences. Faculty of Life Sciences"],"dc:publisher.institution":["University of Bradford"],"dc:rights":["<a rel=\"license\" href=\"http://creativecommons.org/licenses/by-nc-nd/3.0/\"><img alt=\"Creative Commons License\" style=\"border-width:0\" src=\"http://i.creativecommons.org/l/by-nc-nd/3.0/88x31.png\" /></a><br />The University of Bradford theses are licenced under a <a rel=\"license\" href=\"http://creativecommons.org/licenses/by-nc-nd/3.0/\">Creative Commons Licence</a>."],"dc:subject":["Malignant Pleural Mesothelioma (MPM)","Exportin-1","KPT-330","Auranofin","CD-44 receptor","Hydrogel","Nanotechnology","Drug delivery system","Reactive oxygen species (ROS)"],"dc:title":["Drug repurposing and engineering nanotechnology-based delivery systems: A strategy to overcome chemoresistance in Malignant Pleural Mesothelioma"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["doctoral"],"dc:type.qualificationname":["PhD"]},"updated_at":"2026-07-24T01:15:08Z"}